Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 21% ± 3% | |
GABAergic neuron | 3 studies | 27% ± 6% | |
glutamatergic neuron | 3 studies | 35% ± 6% | |
transit amplifying cell | 3 studies | 23% ± 7% | |
oligodendrocyte | 3 studies | 20% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 1651.29 | 21 / 21 | 100% | 29.66 | 504 / 504 |
breast | 100% | 1403.57 | 459 / 459 | 100% | 32.01 | 1118 / 1118 |
esophagus | 100% | 1259.64 | 1445 / 1445 | 100% | 35.59 | 183 / 183 |
ovary | 100% | 1676.44 | 180 / 180 | 100% | 33.08 | 430 / 430 |
prostate | 100% | 1769.14 | 245 / 245 | 100% | 26.78 | 502 / 502 |
stomach | 100% | 1201.19 | 359 / 359 | 100% | 35.81 | 286 / 286 |
uterus | 100% | 1628.14 | 170 / 170 | 100% | 30.79 | 459 / 459 |
lung | 100% | 1283.28 | 577 / 578 | 100% | 29.08 | 1155 / 1155 |
skin | 100% | 1547.33 | 1808 / 1809 | 100% | 32.61 | 471 / 472 |
kidney | 100% | 1251.58 | 89 / 89 | 100% | 21.69 | 898 / 901 |
intestine | 100% | 1342.48 | 966 / 966 | 100% | 32.52 | 525 / 527 |
brain | 99% | 993.48 | 2626 / 2642 | 100% | 24.54 | 705 / 705 |
thymus | 100% | 2095.80 | 653 / 653 | 99% | 21.93 | 601 / 605 |
pancreas | 100% | 1311.65 | 328 / 328 | 99% | 19.98 | 176 / 178 |
adrenal gland | 100% | 1650.19 | 258 / 258 | 99% | 18.95 | 227 / 230 |
liver | 100% | 1064.58 | 226 / 226 | 98% | 16.25 | 396 / 406 |
adipose | 100% | 1237.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.69 | 29 / 29 |
muscle | 100% | 1701.40 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1568.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.51 | 1 / 1 |
blood vessel | 100% | 1143.60 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 969.04 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 1279.38 | 876 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 14.00 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000003 | Biological process | positive regulation of DNA damage checkpoint |
GO_0032006 | Biological process | regulation of TOR signaling |
GO_0050821 | Biological process | protein stabilization |
GO_0031932 | Cellular component | TORC2 complex |
GO_0031931 | Cellular component | TORC1 complex |
GO_0110078 | Cellular component | TTT Hsp90 cochaperone complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | TTI1 |
Protein name | TELO2-interacting protein 1 homolog (Protein SMG10) TELO2 interacting protein 1 |
Synonyms | SMG10 KIAA0406 |
Description | FUNCTION: Regulator of the DNA damage response (DDR). Part of the TTT complex that is required to stabilize protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex is involved in the cellular resistance to DNA damage stresses, like ionizing radiation (IR), ultraviolet (UV) and mitomycin C (MMC). Together with the TTT complex and HSP90 may participate in the proper folding of newly synthesized PIKKs. Promotes assembly, stabilizes and maintains the activity of mTORC1 and mTORC2 complexes, which regulate cell growth and survival in response to nutrient and hormonal signals. . |
Accessions | ENST00000620381.1 ENST00000449821.1 ENST00000373448.6 O43156 ENST00000373447.8 A0A087WT32 |